Researchers have found deuterium depletion complements treatments effectively
Hungarian researchers have found that deuterium depletion, when used as a complementary therapy in cancer treatment, can significantly increase patient survival rates and reduce cancer related mortality by up to 80%.
Deuterium is a stable isotope of hydrogen in the body, containing one proton and one neutron in its nucleus. This sub-molecular regulatory mechanism primarily regulates cell growth, cancer development, and metabolism.
Deuterium depletion alters the ratio of deuterium-to-hydrogen isotope pair, aiming to slow tumour growth and improve treatment outcomes.
The recent study analysed data from 2,649 cancer patients and their use of deuterium-depleted water (DDW) as a complementary therapy.
The addition of DDW extended patients’ expected lifespans. Median survival reached 11.6 years, nearly five times the 2.4-year median survival rate for the Hungarian cancer population.
Further placebo-controlled clinical trials are required to confirm the findings, which indicate a substantial increase in life expectancy following cancer diagnosis.
According to the World Health Organisation, one in five people worldwide has cancer, and by 2050, a 77% increase in newly diagnosed cancer cases is expected.
